Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-07-27

Clinical Trial Update: A Novel, Potent and Non-addictive Analgesic of Combinations for Knee Replacement Moderate to Severe Pain Management [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a novel, potent, non-addictive analgesic combination aimed at moderate to severe postoperative knee replacement pain managemen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sinew Pharma Inc. investigational analgesic combination

Snippet

Sponsor: Sinew Pharma Inc. | Conditions: Pain, Postoperative | Phase 2 | Status: UNKNOWN